Clinical Trials · NCT05071898
Pharmacogenetics of Response to GLP1R Agonists
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- University of Maryland, Baltimore
- Enrollment
- 600
- Start date
- Apr 2022
- Locations
- 1 site, United States
- Primary endpoint
- First phase insulin secretion